SpyGlass Pharma, Inc.
No trades
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−39.87 M USD
0.00 USD
14.50 M
About SpyGlass Pharma, Inc.
Sector
Industry
CEO
Patrick Mooney
Website
Headquarters
Aliso Viejo
Founded
2019
IPO date
Feb 6, 2026
IPO offer price
16.00 USD
Identifiers
3
ISIN US85220G1094
SpyGlass Pharma, Inc. is a late-stage biopharmaceutical, which engages in the development of treatment paradigm for patients living with chronic eye conditions. Its lead product candidate, Bimatoprost Drug Pad-IOL System (BIM-IOL System), is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) for patients who have wither open-angel glaucoma (OAG) or ocular hypertension (OHT). The company was founded in January 2019 by Malik Y. Kahook and Glenn Sussman and is headquartered in Aliso Viejo, CA.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently asked questions
The current price of SGP is 23.82 USD — it has increased by 1.60% in the past 24 hours. Watch SpyGlass Pharma, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange SpyGlass Pharma, Inc. stocks are traded under the ticker SGP.
SGP stock has fallen by −2.97% compared to the previous week, the month change is a 13.07% rise, over the last year SpyGlass Pharma, Inc. has showed a −5.66% decrease.
We've gathered analysts' opinions on SpyGlass Pharma, Inc. future price: according to them, SGP price has a max estimate of 62.00 USD and a min estimate of 37.00 USD. Watch SGP chart and read a more detailed SpyGlass Pharma, Inc. stock forecast: see what analysts think of SpyGlass Pharma, Inc. and suggest that you do with its stocks.
SGP stock is 3.51% volatile and has beta coefficient of 1.50. Track SpyGlass Pharma, Inc. stock price on the chart and check out the list of the most volatile stocks — is SpyGlass Pharma, Inc. there?
Yes, you can track SpyGlass Pharma, Inc. financials in yearly and quarterly reports right on TradingView.
SpyGlass Pharma, Inc. is going to release the next earnings report on Jun 3, 2026. Keep track of upcoming events with our Earnings Calendar.
SGP earnings for the last quarter are −5.72 USD per share, whereas the estimation was −0.57 USD resulting in a −896.14% surprise. The estimated earnings for the next quarter are −0.50 USD per share. See more details about SpyGlass Pharma, Inc. earnings.
SpyGlass Pharma, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
SGP net income for the last quarter is −12.56 M USD, while the quarter before that showed −8.40 M USD of net income which accounts for 0.00% change. Track more SpyGlass Pharma, Inc. financial stats to get the full picture.
No, SGP doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 14, 2026, the company has 65 employees. See our rating of the largest employees — is SpyGlass Pharma, Inc. on this list?
Like other stocks, SGP shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SpyGlass Pharma, Inc. stock right from TradingView charts — choose your broker and connect to your account.